Rigel Pharmaceuticals Settles Patent Dispute Over TAVALISSE® with Annora Pharma Rigel Pharmaceuticals has reached a settlement with Annora Pharma regarding patent litigation over TAVALISSE®, allowing for potential market entry of a generic version by 2032.

Rigel Pharmaceuticals Settles Patent Dispute Over TAVALISSE® with Annora Pharma #United_States #South_San_Francisco #Rigel_Pharmaceuticals #TAVALISSE #Annora_Pharma